At a press conference during the ASCO 2012 Annual Meeting in Chicago, June 1st - June 4th, Dr Thomas Zander presented results from a multicenter study in Germany that reports it is feasible to routinely conduct high-quality molecular analysis of non-small cell lung cancers (NSCLC) in local community hospitals that are not affiliated with academic medical centers.

The study suggests that molecular testing can be made available to more patients, and in many cases, through hospitals closer to patients' homes.